EE270 Predicting Persistent Severe Acute Kidney Injury (AKI) Using the Urinary C-C Motif Chemokine Ligand 14 Biomarker (CCL14). Cost-Utility Analysis in Spain and the UK
Abstract
Authors
R. Martins S. Lobaz P. Jorge-Monjas J. Echeverri J. Shepelev M. Joannidis